“Bimekizumab Impact on Patient-Reported Outcomes in Patients With Moderate to Severe Hidradenitis Suppurativa: Pooled Week 48 Results from BE HEARD I&II”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s476, https://doi.org/10.25251/skin.8.supp.476.